Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Placebo cream application

Preclinical

PPontificia Universidad Catolica de Chile

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Neuropathic Chronic PainNot yet recruiting

Neuropathic Chronic PainPreclinical

Not yet recruiting

Timeline

Expected Milestones

Q4 2026

PreclinicalNot yet recruiting

Neuropathic Chronic Pain

NCT07396129

Clinical

Trials by Indication[1]

Neuropathic Chronic Pain1 trial

Assessing the Efficacy of High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain: A Crossover Study in Elderly Patients Refractory to Pharmacological Treatments

Not yet recruiting·PPontificia Universidad Catolica de Chile·Preclinical·NCT07396129·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Placebo cream application. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Placebo cream application. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Pontificia Universidad Catolica de Chile company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: PPontificia Universidad Catolica de Chile

Related News